Lytic cycle gene regulation of Epstein-Barr virus

Journal of Virology

Volumn 78, Issue 24, 2004, Pages 13460-13469

  Amon, Wolfgang ^a   Binné, Ulrich K ^a,b   Bryant, Helen ^a,c   Jenkins, Peter J ^a,d   Karstegl, Claudio Elgueta ^a   Farrell, Paul J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; VIRUS DNA;

ARTICLE; DNA REPLICATION; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; LYMPHOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TATA BOX; VIRUS REPLICATION;

BASE SEQUENCE; CELL LINE, TUMOR; DNA REPLICATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PLASMIDS; PROMOTER REGIONS (GENETICS); REPLICATION ORIGIN; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 10044224905     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.24.13460-13469.2004     Document Type: Article

References (33)

1. Bell, P., P. M. Lieberman, and G. G. Maul. 2000. Lytic but not latent replication of Epstein-Barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J. Virol. 74:11800-11810.
2. Biggin, M., M. Bodescot, M. Perricaudet, and P. Farrell. 1987. Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells. J. Virol. 61:3120-3132.
3. Binné, U., W. Amon, and P. Farrell. 2002. Promoter sequences required for reactivation of Epstein-Barr virus from latency. J. Virol. 76:10282-10289.
4. Bodescot, M., M. Perricaudet, and P. J. Farrell. 1987. A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus. J. Virol. 61: 3424-3430.
5. Bryant, H., and P. Farrell. 2002. Signal transduction and transcription factor modification during reactivation of Epstein-Barr virus from latency. J. Virol. 76:10290-10298.
6. de Jesus, O., P. R. Smith, L. Spender, C. Elgueta Karstegl, H. Niller, D. Huang, and P. J. Farrell. 2003. Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J. Gen. Virol. 84:1443-1450.
7. Farrell, P. J. 1989. The Epstein-Barr virus genome, p. 103-132. In I. G. Klein (ed.), Advances in viral oncology. Raven Press, New York, N.Y.
8. Farrell, P. J., A. Bankier, C. Seguin, P. Deininger, and B. G. Barrell. 1983. Latent and lytic cycle promoters of Epstein-Barr virus. EMBO J. 2:1331-1338.
9. Furnari, F. B., V. Zacny, E. B. Quinlivan, S. Kenney, and J. S. Pagano. 1994. RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism. J. Virol. 68:1827-1836.
10. Guzowski, J. F., J. Singh, and E. K. Wagner. 1994. Transcriptional activation of the herpes simplex virus type 1 UL38 promoter conferred by the cis-acting downstream activation sequence is mediated by a cellular transcription factor. J. Virol. 68:7774-7789.
11. Guzowski, J. F., and E. K. Wagner. 1993. Mutational analysis of the herpes simplex virus type 1 strict late UL38 promoter/leader reveals two regions critical in transcriptional regulation. J. Virol. 67:5098-5108.
12. Hall, K. T., A. J. Stevenson, D. J. Goodwin, P. C. Gibson, A. F. Markham, and A. Whitehouse. 1999. The activation domain of herpesvirus saimiri R protein interacts with the TATA-binding protein. J. Virol. 73:9756-9763.
13. Hammerschmidt, W., and B. Sugden. 1988. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55:427-433.
14. Jenkins, P., U. Binné, and P. Farrell. 2000. Histone acetylation and reactivation of Epstein-Barr virus from latency. J. Virol. 74:710-720.
15. Johnson, P. A., and R. D. Everett. 1986. The control of herpes simplex virus type-1 late gene transcription: a 'TATA-box'/cap site region is sufficient for fully efficient regulated activity. Nucleic Acids Res. 14:8247-8264.
16. Kibler, P. K., J. Duncan, B. D. Keith, T. Hupel, and J. R. Smiley. 1991. Regulation of herpes simplex virus true late gene expression: sequences downstream from the US11 TATA box inhibit expression from an unreplicated template. J. Virol. 65:6749-6760.
17. Kim, D. B., S. Zabierowski, and N. A. DeLuca. 2002. The initiator element in a herpes simplex virus type 1 late-gene promoter enhances activation by ICP4, resulting in abundant late-gene expression. J. Virol. 76:1548-1558.
18. Kraus, R., J. G. Perrigoue, and J. Mertz. 2003. ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus. J. Virol. 77:199-207.
19. Kraus, R. J., S. J. Mirocha, H. M. Stephany, J. R. Puchalski, and J. E. Mertz. 2001. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus. J. Virol. 75:867-877.
20. Manet, E., H. Gruffat, M. C. Trescol-Biemont, N. Moreno, P. Chambard, J. F. Giot, and A. Sergeant. 1989. Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators. EMBO J. 8:1819-1826.
21. Packham, G., M. Brimmell, D. Cook, A. Sinclair, and P. Farrell. 1993. Strain variation in Epstein-Barr virus immediate early genes. Virology 192:541-550.
22. Polack, A., G. Hartl, U. Zimber, U. K. Freese, G. Laux, K. Takaki, B. Hohn, L. Gissmann, and G. W. Bornkamm. 1984. A complete set of overlapping cosmid clones of M-ABA virus derived from nasopharyngeal carcinoma and its similarity to other Epstein-Barr virus isolates. Gene 27:279-288.
23. Roizman, B., and D. Knipe. 2001. Herpes simplex viruses and their replication, p. 2425-2426. In D. Knipe and P. Howley (ed.), Fields virology, vol. 2. Lippincott, Williams and Wilkins, Philadelphia, Pa.
24. Roizman, B., and P. Pellett. 2001. The family Herpesviridae: a brief introduction, p. 2388-2394. In D. Knipe and P. Howley (ed.), Fields virology, fourth ed., vol. 2. Lippincott, Williams & Wilkins, Philadelphia, Pa.
25. 2 gene. J. Virol. 66:4855-4863.
26. Serio, T. R., N. Cahill, M. E. Prout, and G. Miller. 1998. A functionally distinct TATA box required for late progression through the Epstein-Barr virus life cycle. J. Virol. 72:8338-8343.
27. Serio, T. R., J. L. Kolman, and G. Miller. 1997. Late gene expression from the Epstein-Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis. J. Virol. 71:8726-8734.
28. Takada, K., and Y. Ono. 1989. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63:445-449.
29. Tribouley, C., P. Lutz, A. Staub, and C. Kedinger. 1994. The product of the adenovirus intermediate gene IVa2 is a transcriptional activator of the major late promoter. J. Virol. 68:4450-4457.
30. Weir, J. P., and P. R. Narayanan. 1990. Expression of the herpes simplex virus type 1 glycoprotein C gene requires sequences in the 5′ noncoding region of the gene. J. Virol. 64:445-449.
31. Whitehouse, A., I. M. Carr, J. C. Griffiths, and D. M. Meredith. 1997. The herpesvirus saimiri ORF50 gene, encoding a transcriptional activator homologous to the Epstein-Barr virus R protein, is transcribed from two distinct promoters of different temporal phases. J. Virol. 71:2550-2554.
32. Yates, J. L., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313: 812-815.
33. Zalani, S., E. Holley-Guthrie, and S. Kenney. 1996. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc. Natl. Acad. Sci. USA 93:9194-9199.